{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T03:29:40Z","timestamp":1791948580304,"version":"4.3.4"},"reference-count":6,"publisher":"American Medical Association (AMA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2024,2,13]]},"abstract":"<jats:p>This study assesses the proportion of US substance use and mental health care facilities that offered any medications for opioid use disorder and, specifically, long-acting injectable buprenorphine in 2021.<\/jats:p>","DOI":"10.1001\/jama.2023.26522","type":"journal-article","created":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T11:00:36Z","timestamp":1705575636000},"page":"524","source":"Crossref","is-referenced-by-count":8,"title":["Availability of Long-Acting Injectable Buprenorphine at Substance Use Treatment Facilities in 2021"],"prefix":"10.1001","volume":"331","author":[{"given":"Nitin","family":"Vidyasagar","sequence":"first","affiliation":[{"name":"Pritzker School of Medicine, The University of Chicago, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel R.","family":"Bunting","sequence":"additional","affiliation":[{"name":"Department of Psychiatry & Behavioral Neuroscience, The University of Chicago, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vineet M.","family":"Arora","sequence":"additional","affiliation":[{"name":"Pritzker School of Medicine, The University of Chicago, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mim","family":"Ari","sequence":"additional","affiliation":[{"name":"Department of Medicine, The University of Chicago, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"8","key":"jld230089r1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.27488","article-title":"Use of medication for opioid use disorder among adults with past-year opioid use disorder in the US, 2021.","volume":"6","author":"Jones","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"2","key":"jld230089r3","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1176\/appi.ps.202000165","article-title":"Availability of extended-release buprenorphine to treat opioid use disorders among medicaid-covered patients.","volume":"72","author":"Shover","year":"2021","journal-title":"Psychiatr Serv"},{"issue":"5","key":"jld230089r6","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1377\/hlthaff.2022.01513","article-title":"Buprenorphine treatment for opioid use disorder: comparison of insurance restrictions, 2017\u201321: study examines insurance restrictions on buprenorphine treatment for opioid use disorder.","volume":"42","author":"Andraka-Christou","year":"2023","journal-title":"Health Aff (Millwood)"},{"key":"jld230089r2","unstructured":"Drug Enforcement Administration. Buprenorphine. Accessed October 31, 2023. https:\/\/www.deadiversion.usdoj.gov\/drug_chem_info\/buprenorphine.pdf"},{"key":"jld230089r4","unstructured":"Substance Abuse and Mental Health Services Administration. National Substance Use and Mental Health Services Survey (N-SUMHSS), 2021: codebook. Accessed April 17, 2023. https:\/\/www.datafiles.samhsa.gov\/sites\/default\/files\/field-uploads-protected\/studies\/N-SUMHSS-2021\/N-SUMHSS-2021-datasets\/N-SUMHSS-2021-DS0001\/N-SUMHSS-2021-DS0001-info\/N-SUMHSS-2021-DS0001-info-codebook.pdf"},{"key":"jld230089r5","unstructured":"Delivery of a Controlled Substance by a Pharmacy to an Administering Practitioner, 21 USC \u00a7116 (2024). Accessed July 26, 2023. https:\/\/uscode.house.gov\/view.xhtml?req=granuleid:USC-prelim-title21-section829a&num=0&edition=prelim"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2814255\/jama_vidyasagar_2024_ld_230089_1707775806.7408.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,13]],"date-time":"2024-02-13T11:40:56Z","timestamp":1707824456000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2814255"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,13]]},"references-count":6,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,2,13]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2023.26522","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2,13]]}}}